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Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial 
lung disease of irreversible declining lung function. Reductions in forced vital capacity 
(FVC) and diffusion capacity for carbon monoxide (DLCO) are the common clinical 
endpoints for prognostic monitoring and assessing treatment outcomes. The use of 
cardiopulmonary exercise testing (CPET) in IPF remains largely unexplored. 
Objectives: To explore the feasibility of CPET as a clinical measure in IPF and identify 
associations with established clinical variables.  
Methods: Seventeen patients with IPF were approached, and fifteen (88%) were 
recruited (13 male, 68.1 ± 7.5 years). Incremental exercise testing to exhaustion was 
undertaken via electronically braked cycle ergometer. Variables included:  peak 
oxygen consumption (VO2peak), peak work rate (WRpeak), nadir SpO2, ventilatory drive 
(VE/VCO2), alongside standard clinical pulmonary function tests of FVC and DLCO. 
Pearson’s correlation coefficients established relationships between variables. 
Results: One participant was excluded (high baseline systolic blood pressure). Eight 
out of fourteen (57%) participants reached volitional exhaustion. Five CPETs were 
terminated early due to desaturation (SpO2 < 88%) and one to an exercise-induced 
right bundle branch block (recovery within minutes of ceasing exercise). Mean (± SD) 
pulmonary and exercise results were: FVC, 84.9 ± 17.0 %; DLCO, 56.5 ± 11.4 %; 
VO2peak, 1.4 ± 0.4 L.min-1, 16.5 ± 5.5 mL.kg-1.min-1; WRpeak, 104 ± 42 W; SpO2, 90 ± 3 
%; VE/VCO2, 27.1 ± 6.4. Significant correlations were identified between: FVC and 
SpO2 (r = 0.58, p = 0.032), DLCO and VE/VCO2 (r = 0.81, p < 0.001) and WRpeak (r = 
0.58, p = 0.03). Body-mass relative VO2peak held moderate, but not significant 
relationships with FVC (r = 0.44, p = 0.11) and DLCO (r = 0.53, p = 0.51). 
Conclusions: Initial findings from this study have found CPET to be acceptable to 
patients with IPF and potentially feasible as a testing measure.  Preliminary results 
identified common exercise desaturation, suggesting less conservative SpO2 
termination criteria (e.g. 80% cut-off) could be considered. Although exercise 
parameters held limited relationships with FVC and DLCO, results from VO2peak 
identifies potential additional and dynamic prognostic information and warrants further 
investigation. 
 
 
